Colorado law now allows authorized facilities to stock epinephrine auto-injectors to treat individuals believed to be experiencing anaphylaxis (a sudden, severe and sometimes fatal allergic reaction). Until now, only schools and hospitals were allowed to stock and administer this emergency medicine.
"Now Coloradans will be able to receive help more quickly if they experience an unexpected allergic reaction," said Lynn Trefren, chief of the immunization branch at the Colorado Department of Public Health and Environment. "During the summer months, there is an increased chance of bee stings and other potential allergens. At times, an anaphylactic reaction occurs unexpectedly without a known allergic trigger, and in rare cases that can result in death. Increased access to auto-injectors could counter a life-threatening allergic reaction."
Staff at facilities wanting to stock epinephrine auto-injectors must complete a nationally recognized training course, and obtain the medication from a provider. Facilities will need to submit an online report each time they administer the medicine. To learn more about the requirements and training for a business to stock epinephrine auto-injectors, please visit the department's webpage.